Quick Answer
Aclaris Therapeutics, Inc. reported Total Assets of $160.46 million for fiscal year 2025.
Aclaris Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $160.46M | -27.2% |
| 2024 | $220.33M | +11.6% |
| 2023 | $197.41M | -22.5% |
| 2022 | $254.60M | +1.3% |
| 2021 | $251.21M | +254.9% |
| 2020 | $70.78M | -28.0% |
| 2019 | $98.30M | -64.3% |
| 2018 | $275.57M | +13.2% |
| 2017 | $243.51M | +38.3% |
| 2016 | $176.09M | +87.2% |
| 2015 | $94.08M | +441.4% |
| 2014 | $17.38M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $175.53M | -3.8% | -7.2% |
| June 30, 2025 | $189.15M | +17.4% | -4.5% |
| March 31, 2025 | $198.09M | +13.8% | -10.1% |
| December 31, 2024 | $220.33M | +11.6% | +20.8% |
| September 30, 2024 | $182.39M | -16.5% | +13.2% |
| June 30, 2024 | $161.07M | -31.6% | -7.5% |
| March 31, 2024 | $174.06M | -24.2% | -11.8% |
| December 31, 2023 | $197.41M | -22.5% | -9.6% |
- Aclaris Therapeutics, Inc. showed a decrease of -27.2% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Aclaris Therapeutics, Inc.’s total assets has grown by 823.4% (from $17.38 million to $160.46 million).
- The most recent figure is from Aclaris Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: